Diversified Healthcare Trust Q3 net loss narrows amid occupancy growth

By Reuters News


Overview

  • US healthcare REIT reported Q3 net loss of $50.2 mln vs loss of $164 mln yr ago

  • Q3 loss per share was $0.21 vs loss of $0.68 yr ago

  • Company updated full-year 2026 financial guidance


Outlook

  • iversified Healthcare Trust lowers FY26 normalized FFO guidance to $110.7 mln-$125.7 mln from $135 mln-$150 mln

  • DHC lowers FY26Adjusted EBITDAre guidance to $275.7 mln-$290.7 mln from $300 mln-$315 mln

  • Same Property SHOP NOI guidance rises to $190 mln-$200 mln from $185 mln-$195 mln for FY26


Result Drivers

  • SHOP OCCUPANCY AND RATES – Q3 same-property SHOP NOI rose 50.4% yr/yr, driven by 200-bps occupancy growth and a 5.2% increase in average monthly rates

  • MEDICAL OFFICE LEASING – Leased 130,000 sq. ft. at rents 25.2% above prior levels, with a 9.7-year weighted average lease term

  • SHOP UTILITY COSTS – Same-property SHOP NOI fell q/q as Q2 one-time expense benefits lapped and seasonal utility costsincreased


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Loss Per Share

$0.21

Q3 Net Loss

$50.2 mln


Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the specialized reits peer group is "buy"

  • Wall Street's median 12-month price target for Diversified Healthcare Trust is $10.55, about 35.6% above its October 30 closing price of $7.78


Reuters Recommended Reads

  • Nov 2 - Senior housing REIT Janus Living's Q3 revenue jumps 78%, FFO up 46%

  • Nov 2 - Sabra Health Care REIT Q3 revenue rises year-over-year

  • Nov 2 - Healthpeak Properties Q3 adjusted FFO falls; full year outlook lifted


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.